Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway

BACKGROUND: Effective-component compatibility of Bufei Yishen formula III (ECC-BYF III) demonstrates positive effects on stable chronic obstructive pulmonary disease (COPD). PURPOSE: To investigate the mechanisms of ECC-BYF III on COPD rats from the aspect of airway epithelial cell senescence. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Min-yan, Qin, Yan-qin, Tian, Yan-ge, Li, Kang-chen, Oliver, Brian G., Liu, Xue-fang, Zhao, Peng, Li, Jian-sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682796/
https://www.ncbi.nlm.nih.gov/pubmed/36414945
http://dx.doi.org/10.1186/s12890-022-02191-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682796/
https://www.ncbi.nlm.nih.gov/pubmed/36414945
http://dx.doi.org/10.1186/s12890-022-02191-9

Ejemplares similares